Reasons for acceptance and refusal of early palliative care in patients included in early-phase clinical trials in a regional comprehensive cancer centre in France: protocol for a qualitative study

Gisele Chvetzoff, Magali Girodet, Johanna Despax, Valentine Baudry, Julie Duranti, Bénédicte Mastroianni, Hélène Vanacker, Armelle Vinceneux, Mehdi Brahmi, Olivier Renard, Julien Gautier, Manon Britel, Françoise Ducimetière, Amélie Anota, Philippe Cassier, Véronique Christophe, Gisele Chvetzoff, Magali Girodet, Johanna Despax, Valentine Baudry, Julie Duranti, Bénédicte Mastroianni, Hélène Vanacker, Armelle Vinceneux, Mehdi Brahmi, Olivier Renard, Julien Gautier, Manon Britel, Françoise Ducimetière, Amélie Anota, Philippe Cassier, Véronique Christophe

Abstract

Introduction: A few studies have highlighted the potential synergy between early palliative care and inclusion in an early-phase clinical trial that may improve quality of life, reduce symptoms of exhaustion related to the side effects of treatment and allow patients to complete their treatment protocol. The primary objective of this qualitative study is to evaluate the reasons for acceptance or refusal of early palliative care in patients included in early-phase clinical trials.

Method and analysis: All patients from the Centre Léon Bérard (Comprehensive Cancer Centre in Lyon, France) who consent to one of the early-phase clinical trials proposed at the centre will be invited to participate in this study. The cohort will consist of a subgroup (n=20) of patients who accept palliative care together with their clinical trial, and a second subgroup (n=20) of patients who decline it. Patients will be interviewed in exploratory interviews conducted by a psychology researcher before the start of their clinical trial. The interviews will be audio-recorded. Patients will also be asked to complete quality of life and anxiety/depression questionnaires both before the beginning of the treatment and at the end of their clinical trial. The content of the interviews will be analysed thematically. Descriptive and comparative statistical analysis of both cohorts will also be conducted.

Ethics and dissemination: Personal data will be collected and processed in accordance with the laws and regulations in force. All patients will give informed consent to participate. This study complies with reference methodology MR004 of the Commission Nationale de l'Informatique et des Libertés. The protocol has received the validation of an ethics committee (Groupe de Réflexion Ethique du CLB, number: 2020-006). The results will be disseminated through conference presentations and peer-reviewed publications.

Trial registration number: NCT04717440.

Keywords: Adult oncology; Adult palliative care; QUALITATIVE RESEARCH.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Data collection procedures. FACT-G7, seven-item Functional Assessment of Cancer Therapy-General.

References

    1. Chakiba C, Grellety T, Bellera C, et al. . Encouraging trends in modern phase 1 oncology trials. N Engl J Med 2018;378:2242–3. 10.1056/NEJMc1803837
    1. Earle CC, Landrum MB, Souza JM, et al. . Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol 2008;26:3860–6. 10.1200/JCO.2007.15.8253
    1. Bell JAH, Balneaves LG. Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy. Support Care Cancer 2015;23:1169–96. 10.1007/s00520-014-2581-9
    1. Catt S, Langridge C, Fallowfield L, et al. . Reasons given by patients for participating, or not, in phase 1 cancer trials. Eur J Cancer 2011;47:1490–7. 10.1016/j.ejca.2011.02.020
    1. Jenkins VA, Anderson JL, Fallowfield LJ. Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009. Support Care Cancer 2010;18:1115–21. 10.1007/s00520-010-0836-7
    1. Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer 2000;36:621–6. 10.1016/S0959-8049(99)00330-5
    1. Pentz RD, White M, Harvey RD, et al. . Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials. Cancer 2012;118:4571–8. 10.1002/cncr.27397
    1. Derbez B. Les paradoxes du care dans les essais cliniques de phase I en oncologie. Sci Soc Sante 3 avr 2018;36:5–29. 10.3917/sss.361.0005
    1. Lynöe N, Sandlund M, Dahlqvist G, et al. . Informed consent: study of quality of information given to participants in a clinical trial. BMJ 1991;303:610–3. 10.1136/bmj.303.6803.610
    1. Gota V, Nookala M, Yadav A. Quality of informed consent in cancer clinical trials in India: a cross-sectional survey. JCO 2015;33:e17652. 10.1200/jco.2015.33.15_suppl.e17652
    1. Schaeffer MH, Krantz DS, Wichman A, et al. . The impact of disease severity on the informed consent process in clinical research. Am J Med 1996;100:261–8. 10.1016/S0002-9343(97)89483-1
    1. Cohen L, de Moor C, Amato RJ. The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a phase I cancer clinical trial. Cancer 2001;91:1949–55. 10.1002/1097-0142(20010515)91:10<1949::AID-CNCR1218>;2-A
    1. Fernandez-Petite M. Qualité de vie en soins palliatifs : discours et représentations des patients. InfoKara 2007;22:105–10.
    1. Ferrell BR, Chung V, Koczywas M, et al. . Palliative care and phase 1 trials: intervention to improve quality of life and provide education. Clin J Oncol Nurs 2017;21:473–9. 10.1188/17.CJON.473-479
    1. Thienprayoon R, LeBlanc T. Early integration of palliative care into the care of patients with cancer. Hematology Am Soc Hematol Educ Program 2015;2015:479–83. 10.1182/asheducation-2015.1.479
    1. Bakitas M, Lyons KD, Hegel MT, et al. . Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the project enable II randomized controlled trial. JAMA 2009;302:741–9. 10.1001/jama.2009.1198
    1. Temel JS, Greer JA, Muzikansky A, et al. . Early palliative care for patients with metastatic Non–Small-Cell lung cancer. N Engl J Med Overseas Ed 2010;363:733–42. 10.1056/NEJMoa1000678
    1. Zimmermann C, Swami N, Krzyzanowska M, et al. . Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 2014;383:1721–30. 10.1016/S0140-6736(13)62416-2
    1. Smith TJ, Temin S, Alesi ER. American Society of clinical oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012.
    1. INCa . Stratégie décennale de Lutte Contre les cancers 2021-2030, 2021.
    1. Aubry R, D’Hérouville D, Dayde MC, et al. . Soins palliatifs et soins de support. Oncologie 2005;7:203–8. 10.1007/s10269-005-0192-2
    1. Bruera E, Yennurajalingam S. Palliative care in advanced cancer patients: how and when? Oncologist 2012;17:267–73. 10.1634/theoncologist.2011-0219
    1. Ceccaldi J. 18. L’annonce palliative [Internet]. Vol. 2ème ed. Dunod, 2017. Available: [Accessed 8 Nov 2021].
    1. LeBlanc TW, El-Jawahri A. When and why should patients with hematologic malignancies see a palliative care specialist? Hematology 2015;2015:471–8. 10.1182/asheducation-2015.1.471
    1. Zhuang H, Ma Y, Wang L, et al. . Effect of early palliative care on quality of life in patients with non-small-cell lung cancer. Curr Oncol 2018;25:54–8. 10.3747/co.25.3639
    1. Cassel JB, Del Fabbro E, Arkenau T, et al. . Phase I Cancer Trials and Palliative Care: Antagonism, Irrelevance, or Synergy? J Pain Symptom Manage 2016;52:437–45. 10.1016/j.jpainsymman.2016.02.014
    1. Davis MP, Temel JS, Balboni T, et al. . A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med 2015;4:99–121. 10.3978/j.issn.2224-5820.2015.04.04
    1. Haun MW, Estel S, Rücker G, et al. . Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev 2017;6:CD011129. 10.1002/14651858.CD011129.pub2
    1. Hui D, Parsons H, Nguyen L, et al. . Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. Cancer 2010;116:4402–9. 10.1002/cncr.25389
    1. Markman M. Why should phase 1 cancer trial participation and optimal end-of-life care be incompatible? Oncology 2017;92:1–2. 10.1159/000452161
    1. Saunders B, Sim J, Kingstone T, et al. . Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant 2018;52:1893–907. 10.1007/s11135-017-0574-8
    1. Conroy T, Mercier M, Bonneterre J, et al. . French version of FACT-G: validation and comparison with other cancer-specific instruments. Eur J Cancer 2004;40:2243–52. 10.1016/j.ejca.2004.06.010
    1. Mah K, Swami N, Le LW, et al. . Validation of the 7-item functional assessment of cancer Therapy-General (FACT-G7) as a short measure of quality of life in patients with advanced cancer. Cancer 2020;126:3750–7. 10.1002/cncr.32981
    1. Razavi D, Delvaux N, Farvacques C. Validation de la version Française Du HADS dans une population de patients cancéreux hospitalisés. Rev Psychol Appliquée 1989;39:295–307.
    1. Molin Y, Gallay C, Gautier J, et al. . PALLIA-10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: a prospective multicentric study (PREPA-10). Cancer Med 2019;8:2950–61. 10.1002/cam4.2118
    1. Bourgeois H, Grudé F, Solal-Céligny P, et al. . Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study. Ann Oncol 2017;28:1612–7. 10.1093/annonc/mdx172
    1. Pautex S, Vayne-Bossert P, Bernard M, et al. . Validation of the French version of the Edmonton symptom assessment system. J Pain Symptom Manage 2017;54:721–6. 10.1016/j.jpainsymman.2017.07.032
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 10.1191/1478088706qp063oa
    1. Creswell JW, Poth CN. Qualitative inquiry and research design: choosing among five approaches. Sage Publications, 2016: 1–489.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit